US Stocks
/
Altimmune, Inc. Share Price
Altimmune, Inc. Share Price

Altimmune, Inc. Share Price

NASDAQ: ALT | Micro Cap
$2.60
-$0.06 (-2.44%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Altimmune, Inc. Stock Performance

Open
$2.66
Prev. Close
$2.67
Circuit Range
N/A
Day Range
$2.55 - $2.66
Year Range
$2.55 - $6.42
Volume
96,099
Average Traded
$2.59

Altimmune, Inc. Share Price Today

As of 9 October 2026, Altimmune, Inc.'s share price is $2.60. The stock opened at $2.66, compared to its previous close of $2.67. During today's trading session, Altimmune, Inc.'s share price traded between $2.55 and $2.66, with an average price of $2.60. Over the past 52 weeks, the stock has recorded a high of $6.42 and a low of $2.55. In terms of performance, Altimmune, Inc.'s share price has risen by 0.78% over the last six months and is down 35.80% on a year-on-year basis.

Altimmune, Inc. Share Price Chart

$2.55$2.66
L
Show Current Price
H

Altimmune, Inc. Stock Fundamentals & Key Indicators

Market Cap
$229.07M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.47
Revenue (TTM)
$40.00M
Return On Equity (TTM)
-19.41%
Profit Margin
-220225.00%
Debt to Equity
0.07
Quarterly Earnings Growth YoY
-20.09%

Altimmune, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.01$0.03$0.00$0.00
Net Profit-$19.01-$27.36-$22.86-$22.83
Net Profit Margin-190100.00%-91200.00%N/AN/A
Income ChangeN/A-43.92%16.45%0.13%

Altimmune, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue-$0.07$0.43$0.02$0.04
Net Profit-$84.71-$88.45-$95.06-$88.09
Net Profit Margin121014.29%-20569.77%-475300.00%-220225.00%
Income ChangeN/A-4.42%-7.47%7.33%

About Altimmune, Inc.

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Altimmune, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.85
$2.60
-9.42%
Sep 2026
$3.08
$2.87
-11.71%
Aug 2026
$2.90
$3.25
+13.86%
Jul 2026
$3.06
$2.85
-5.79%
Jun 2026
$3.03
$3.02
-0.82%
May 2026
$2.57
$3.05
+18.22%
Apr 2026
$3.15
$2.58
-15.96%
Mar 2026
$4.22
$3.07
-28.77%
Feb 2026
$5.55
$4.31
-23.17%
Jan 2026
$3.62
$5.61
+55.62%
Dec 2025
$5.08
$3.60
-31.46%
Nov 2025
$4.02
$5.26
+29.88%

ALT Share Price FAQs

What is Altimmune, Inc. share price today?

chevron-up
Altimmune, Inc. share price today is $2.60 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Altimmune, Inc. stock?

chevron-up
The 52 week high of Altimmune, Inc. stock is $6.42, while the 52 week low is $2.55 as of 9 Oct '26.

What is ALT's market capitalisation today?

chevron-up
ALT market capitalisation is $229.07M as of October 9, 2026, at 1:37 pm IST.

What is ALT's net income for the last quarter?

chevron-up
ALT's net income for the last quarter is -22.83B USD.

What is the 5 year returns of ALT?

chevron-up
The 5 year returns of ALT is -75.93% as on 9 Oct '26.

What is the high & low stock price of ALT today?

chevron-up
ALT stock price hit a high of $2.66 and low of $2.55 as of 9 Oct '26.

Can I buy ALT shares in India?

chevron-up
Yes. You can buy ALT in India by opening an international trading account.